By Vivek Kumar M and Bharath Rajeswaran (Reuters) – After a punishing few months, India’s benchmark NSE Nifty 50 index is poised for a relief rally in February, based on the changes in investors’ positioning in the derivatives markets, brokerages said. The Nifty has tumbled 11.3% over the last four monthly derivatives series, each of …
Derivatives data signals relief rally for Indian stocks, brokerages say Read More »
By Jaspreet Kalra MUMBAI (Reuters) – The Reserve Bank of India’s $5 billion 6-month dollar/rupee buy-sell swap auction was oversubscribed five-fold on Friday, with the central receiving bids totaling $25.59 billion from 253 participants. The swap will infuse rupee liquidity into the banking system and is part of a swathe of the central bank’s measures …
India cenbank infuses $5.1 billion worth of rupee liquidity via buy/sell FX swap Read More »
(Reuters) – Indian consumer goods maker Marico reported a smaller-than-expected quarterly profit on Friday, as higher raw material costs and marketing spends overshadowed price increases-led growth. Rising prices of raw materials including copra and vegetable oil weighed on the Parachute coconut oil maker’s profits, while the company also faces intense competition and continues to spend …
India’s Marico misses profit estimates as costs overshadow price-led growth Read More »
By Siddhi Nayak MUMBAI (Reuters) – Bank of Baroda, India’s third-largest state-run lender by assets, aims to double its balance sheet in five years while gaining market share and curtailing costs, its chief executive said on Friday. “This is a very realistic target,” Debadatta Chand said in an interview in Mumbai. “In the process, we …
India’s Bank of Baroda aims to double balance sheet in five years, CEO says Read More »
MUMBAI (Reuters) – India’s financial sector regulators need to put in place a formal process to assess the impact of their regulations, the government’s Economic Survey said on Friday. The survey, presented a day ahead of the annual budget, details the state of the economy while flagging longer-term economic and policy issues. Its suggestions and …
India financial regulators need formal impact assessment rules, government report says Read More »
MUMBAI (Reuters) – India’s sugar output during the 2024/25 marketing year ending in September 2025 may fall to 27.27 million metric tons, down 14.7% from a year ago, as mills are likely to divert more sugar for ethanol production, a trade body said on Friday. Mills are likely to divert 3.75 million tons of sugar …
India’s sugar output to fall 14.7% y/y in 2024/25, says trade body Read More »
MUMBAI (Reuters) – A sharp correction in the equity markets could hurt sentiment and spending by India’s retail investors, the government’s Economic Survey said on Friday. The survey, presented a day ahead of the annual budget, details the state of the economy while flagging longer-term economic and policy issues. Retail investors’ participation in India’s equity …
(Reuters) -Nestle India reported a quarterly profit below market expectations on Friday, as a slowdown in consumer spending in major cities and higher product prices dampened its sales. Consumer goods makers are struggling to sustain profits due to inflation in palm oil, coffee and cocoa, while slow wage growth and higher prices of essentials like …
Nestle’s India unit misses profit view on sluggish urban demand Read More »
HYDERABAD (Reuters) – Indian biopharma company Biocon reported third-quarter revenue on Thursday that fell about 3% when compared with the year-earlier period, which included revenue from its domestic branded formulation business that has since been divested. The Bengaluru-based company, which counts the U.S. as its key market, reported revenue from operations of 38.2 billion rupees …
Biocon’s Q3 revenue dips; banks on obesity drugs for future growth Read More »
(Reuters) – India’s Jubilant Pharmova reported a 51% jump in third-quarter profit on Friday, driven by a strong demand for its drugs with radioactive ingredients, used to treat cancer and other diseases. Consolidated net profit rose to 1.01 billion rupees ($11.7 million) in the quarter ended Dec. 31, from 668 million rupees a year ago. …
India’s Jubilant Pharmova posts 51% jump in Q3 profit on strong demand Read More »
